FindTrial
Sign In

Renal function decline and its impact on adjuvant chemotherapy regimen and prognosis following minimally invasive radical nephroureterectomy: an internaltional multi-center study

Renal function decline and its impact on adjuvant chemotherapy regimen and prognosis following minimally invasive radical nephroureterectomy: an internaltional multi-center study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048451
Enrollment
Unknown
Registered
2021-07-08
Start date
2019-07-14
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Tract Urothelial Cancers

Interventions

Case series:none

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients underwent minimally invasive (robotic or laparoscopic) radical nephroureterectomy for upper tract urothelial cancers.

Exclusion criteria

Exclusion criteria: 1. preoperative metastatic diseases; 2. anatomically single kidney; 3. missing data in predictors.

Design outcomes

Primary

MeasureTime frame
Postoperative renal function decline;—

Countries

Italy

Contacts

Public ContactLinhui Wang

Shanghai Changhai Hospital

wanglinhui@smmu.edu.cn+8613901635510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026